Back to CVE records
High 8.8Published Feb 9, 2026

CVE-2026-25497Craft is a platform for creating digital experiences.

Updated under an hour ago ()

Does this affect you?

It affects craftcms craft_cms. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Craft is a platform for creating digital experiences. In Craft versions from 4.0.0-RC1 to before 4.17.0-beta.1 and 5.9.0-beta.1, there is a Privilege Escalation vulnerability in Craft CMS’s GraphQL API that allows an authenticated user with write access to one asset volume to escalate their privileges and modify/transfer assets belonging to any other volume, including restricted or private volumes to which they should not have access. The saveAsset GraphQL mutation validates authorization against the schema-resolved volume but fetches the target asset by ID without verifying that the asset belongs to the authorized volume. This allows unauthorized cross-volume asset modification and transfer. This vulnerability is fixed in 4.17.0-beta.1 and 5.9.0-beta.1.

CVSS
8.8 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-639
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Jun 17, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
craftcms craft_cms
craftcms:craft_cms
after 4.0.0 before 4.17.0; after 5.0.0 before 5.9.0; 4.0.0; 4.0.0; 4.0.0; 4.0.0; 5.0.0; 5.0.0
NVD

References

  • patch
  • release-notes
  • patch, vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.